Applied Bioystems has promoted Mark Stevenson from president of the Molecular and Cell Division to executive vice president of the company. ABI said the Molecular and Cell Division will also be split into two groups: MCB Systems and MCB Consumables.
Alnylam has named Philip Chase to be vice president of legal affairs, Eric Raichle vice president of human resources, and Jason Rhodes vice president of business development.
ImmunoGen announced last week that Senior Vice President of Corporate Development and Operations Pauline Ryan has resigned from the company to pursue other interests. ImmunoGen is searching for a replacement for Ryan. In the transition period, day-to-day responsibilities will be handled by other members of ImmunoGen’s senior management team, the company said.
Prodesse announced this week that it has elected Ira Marks to its board of directors. With more than 30 years of diagnostic and pharmaceutical industry experience, Marks held various positions with Bio-Rad, Nanogen, and Cepheid. He is currently general manager of MiltenyiBiotec.
OxiGene has named Patricia Walicke as its new chief medical officer and vice president. Walicke will replace Peter Harris, the company’s current chief medical officer. Walicke comes to OxiGene from the Amgen subsidiary Avidia, where she was vice president of clinical and regulatory affairs. Walicke has also held various posts in Rinat Neurosciences, Genentech, and Quintiles.
Gene Logic announced this week that Stephen Donahue will be its senior vice president of clinical development. Donahue will lead the Gene Logic’s clinical development efforts for its drug repositioning business. Donahue was previously vice president of clinical research and operations at Epix Pharmaceutical. He has also held positions at Merck and Bristol-Myers Squibb.